These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2741639)

  • 1. Skeletal muscle potassium increases after diet and weight reduction in obese subjects with normal and impaired glucose tolerance.
    Landin K; Lindgärde F; Saltin B
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):21-6. PubMed ID: 2741639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased skeletal muscle potassium in obesity.
    Landin K; Lindgärde F; Saltin B; Wilhelmsen L
    Acta Med Scand; 1988; 223(6):507-13. PubMed ID: 3389206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects.
    Henry RR; Wiest-Kent TA; Scheaffer L; Kolterman OG; Olefsky JM
    Diabetes; 1986 Feb; 35(2):155-64. PubMed ID: 3510922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased skeletal muscle Na/K-ratio in obese men, but not in women, with glucose intolerance.
    Landin K; Lindgärde F; Saltin B; Wilhelmsen L
    J Intern Med; 1989 Feb; 225(2):89-94. PubMed ID: 2921598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a behavioral weight loss program stressing calorie restriction versus calorie plus fat restriction in obese individuals with NIDDM or a family history of diabetes.
    Pascale RW; Wing RR; Butler BA; Mullen M; Bononi P
    Diabetes Care; 1995 Sep; 18(9):1241-8. PubMed ID: 8612437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of non-pharmacological intervention in obese patients with newly diagnosed diabetes mellitus type II].
    Gilis-Januszewska A; Szurkowska M; Szybiński K; Głab G; Szybiński Z; Spodaryk K; Urbanik A
    Pol Arch Med Wewn; 2001 Sep; 106(3):853-60. PubMed ID: 11928596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of impaired glucose tolerance and type II diabetes on resting metabolic rate and thermic response to a glucose meal in obese women.
    Nair KS; Webster J; Garrow JS
    Metabolism; 1986 Jul; 35(7):640-4. PubMed ID: 3523118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of total body potassium during rapid weight loss does not depend on the decrease of potassium concentration in muscles. Different methods to evaluate body composition during a low energy diet.
    Krotkiewski M; Landin K; Mellström D; Tölli J
    Int J Obes Relat Metab Disord; 2000 Jan; 24(1):101-7. PubMed ID: 10702758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.
    Kim YB; Kotani K; Ciaraldi TP; Henry RR; Kahn BB
    Diabetes; 2003 Aug; 52(8):1935-42. PubMed ID: 12882908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss.
    Poynten AM; Markovic TP; Maclean EL; Furler SM; Freund J; Chisholm DJ; Campbell LV
    Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1212-8. PubMed ID: 14513069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate tolerance improves with fasting in obese subjects with noninsulin-dependent (type II) diabetes.
    Watts NB; DiGirolamo M
    Am J Med Sci; 1990 Apr; 299(4):250-6. PubMed ID: 2181873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes.
    Christiansen MP; Linfoot PA; Neese RA; Hellerstein MK
    Diabetes; 2000 Oct; 49(10):1691-9. PubMed ID: 11016453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and long-term effects of acute caloric deprivation in obese diabetic patients.
    Bauman WA; Schwartz E; Rose HG; Eisenstein HN; Johnson DW
    Am J Med; 1988 Jul; 85(1):38-46. PubMed ID: 3291612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.
    Low CC; Grossman EB; Gumbiner B
    Diabetes; 1996 May; 45(5):569-75. PubMed ID: 8621005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
    Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
    Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
    Markovic TP; Jenkins AB; Campbell LV; Furler SM; Kraegen EW; Chisholm DJ
    Diabetes Care; 1998 May; 21(5):687-94. PubMed ID: 9589225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body composition and muscle constituents during weight loss: studies in obese patients following gastroplasty.
    Wadström C; Backman L; Forsberg AM; Nilsson E; Hultman E; Reizenstein P; Ekman M
    Obes Surg; 2000 Jun; 10(3):203-13. PubMed ID: 10932257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.